HIF-1α promotes the keloid development through the activation of TGF-β/Smad and TLR4/MyD88/NF-κB pathways

References

• Lu WS, Zheng XD, Yao XH, et al. Clinical and epidemiological analysis of keloids in Chinese patients. Arch Dermatol Res. 2015;307:109–114.
   PubMed Web of Science ®Google Scholar
• Ud-Din S, Bayat A. New insights on keloids, hypertrophic scars, and striae. Dermatol Clin. 2014;32:193–209.
   PubMed Web of Science ®Google Scholar
• Mofikoya BO, Adeyemo WL, Abdus-salam AA. Keloid and hypertrophic scars: a review of recent developments in pathogenesis and management. Nig Q J Hosp Med. 2007;17:134–139.
   PubMedGoogle Scholar
• Mari W, Alsabri SG, Tabal N, et al. Novel insights on understanding of keloid scar: article review. J Am Coll Clin Wound Spec. 2015;7:1–7.
   PubMedGoogle Scholar
• Celeste CJ, Deschene K, Riley CB, et al. Regional differences in wound oxygenation during normal healing in an equine model of cutaneous fibroproliferative disorder. Wound Repair Regen. 2011;19:89–97.
   PubMed Web of Science ®Google Scholar
• Schreml S, Szeimies RM, Prantl L, et al. Oxygen in acute and chronic wound healing. Br J Dermatol. 2010;163:257–268.
   PubMed Web of Science ®Google Scholar
• Pouyssegur J, Dayan F, Mazure NM. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature. 2006;441:437–443.
   PubMed Web of Science ®Google Scholar
• Freedman SJ, Sun Z-YJ, Poy F, et al. Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 alpha. Proc Natl Acad Sci U S A. 2002;99:5367–5372.
   PubMed Web of Science ®Google Scholar
• Kaluz S, Kaluzova M, Stanbridge EJ. Regulation of gene expression by hypoxia: integration of the HIF-transduced hypoxic signal at the hypoxia-responsive element. Clin Chim Acta. 2008;395:6–13.
   PubMed Web of Science ®Google Scholar
• Gordon KJ, Blobe GC. Role of transforming growth factor-beta superfamily signaling pathways in human disease. Biochim Biophys Acta. 2008;1782:197–228.
   PubMed Web of Science ®Google Scholar
• Naim R, Naumann A, Barnes J, et al. Transforming growth factor-beta1-antisense modulates the expression of hepatocyte growth factor/scatter factor in keloid fibroblast cell culture. Aesthetic Plast Surg. 2008;32:346–352.
   PubMed Web of Science ®Google Scholar
• Seki E, De Minicis S, Osterreicher CH, et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med. 2007;13:1324–1332.
   PubMed Web of Science ®Google Scholar
• Campbell MT, Hile KL, Zhang H, et al. Toll-like receptor 4: a novel signaling pathway during renal fibrogenesis. J Surg Res. 2011;168:e61–69.
   PubMed Web of Science ®Google Scholar
• Chen J, Zeng B, Yao H, et al. The effect of TLR4/7 on the TGF-beta-induced Smad signal transduction pathway in human keloid. Burns. 2013;39:465–472.
   PubMed Web of Science ®Google Scholar
• Tan WQ, Gao ZJ, Xu JH, et al. Inhibiting scar formation in vitro and in vivo by adenovirus-mediated mutant Smad4: a preliminary report. Exp Dermatol. 2011;20:119–124.
   PubMed Web of Science ®Google Scholar
• Distler JH, Jüngel A, Pileckyte M, et al. Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis. Arthritis Rheumatism. 2007;56:4203–4215.
   PubMed Web of Science ®Google Scholar
• Bozova S, Elpek GO. Hypoxia-inducible factor-1alpha expression in experimental cirrhosis: correlation with vascular endothelial growth factor expression and angiogenesis. APMIS. 2007;115:795–801.
   PubMed Web of Science ®Google Scholar
• Moon JO, Welch TP, Gonzalez FJ, et al. Reduced liver fibrosis in hypoxia-inducible factor-1alpha-deficient mice. Am J Physiol Gastrointest Liver Physiol. 2009;296:G582–592.
   PubMed Web of Science ®Google Scholar
• Pakyari M, Farrokhi A, Maharlooei MK, et al. Critical role of transforming growth factor beta in different phases of wound healing. Adv Wound Care (New Rochelle). 2013;2:215–224.
   PubMedGoogle Scholar
• Berse B, Hunt JA, Diegel RJ, et al. Hypoxia augments cytokine (transforming growth factor-beta (TGF-beta) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts. Clin Exp Immunol. 1999;115:176–182.
   PubMed Web of Science ®Google Scholar
• Mingyuan X, Qianqian P, Shengquan X, et al. Hypoxia-inducible factor-1alpha activates transforming growth factor-beta1/Smad signaling and increases collagen deposition in dermal fibroblasts. Oncotarget. 2018;9:3188–3197.
   PubMedGoogle Scholar
• Xue H, McCauley RL, Zhang W. Elevated interleukin-6 expression in keloid fibroblasts. J Surg Res. 2000;89:74–77.
   PubMed Web of Science ®Google Scholar
• Ghazizadeh M, Tosa M, Shimizu H, et al. Functional implications of the IL-6 signaling pathway in keloid pathogenesis. J Invest Dermatol. 2007;127:98–105.
   PubMed Web of Science ®Google Scholar
• Barcelos RP, Bresciani G, Cuevas MJ, et al. Diclofenac pretreatment modulates exercise-induced inflammation in skeletal muscle of rats through the TLR4/NF-kappaB pathway. Appl Physiol Nutr Metab = Physiologie Appliquee, Nutrition Et Metabolisme. 2017;42:757–764.
   PubMed Web of Science ®Google Scholar
• Ren K, Yong C, Yuan H, et al. TNF-alpha inhibits SCF, ghrelin, and substance P expressions through the NF-kappaB pathway activation in interstitial cells of Cajal. Brazilian J Med Biolog Res [Revista brasileira de pesquisas medicas e biologicas]. 2018;51:e7065 doi:10.1590/1414-431x20187065.
   Google Scholar
• Wang H, Pan JQ, Luo L, et al. NF-kappaB induces miR-148a to sustain TGF-beta/Smad signaling activation in glioblastoma. Mol Cancer. 2015;14:2.
   PubMed Web of Science ®Google Scholar
• Yao Z, Seger R. The ERK signaling cascade–views from different subcellular compartments. Biofactors. 2009;35,:407–416.
   PubMed Web of Science ®Google Scholar
• Shaul YD, Seger R. The MEK/ERK cascade: from signaling specificity to diverse functions. Biochim Biophys Acta. 2007;1773:1213–1226.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Oh CK, Messadi DV, et al. Hypoxia-induced HIF-1 alpha accumulation is augmented in a co-culture of keloid fibroblasts and human mast cells: involvement of ERK1/2 and PI-3K/Akt. Exp Cell Res. 2006;312:145–155.
   PubMed Web of Science ®Google Scholar
• Wolfram D, Tzankov A, Pulzl P, et al. Hypertrophic scars and keloids–a review of their pathophysiology, risk factors, and therapeutic management. Dermatologic Surg. 2009;35:171–181.
   PubMed Web of Science ®Google Scholar
• Gupta S, Sharma VK. Standard guidelines of care: keloids and hypertrophic scars. Indian J Dermatol Venereol Leprol. 2011;77:94–100.
   PubMed Web of Science ®Google Scholar
• Kontochristopoulos G, Stefanaki C, Panagiotopoulos A, et al. Intralesional 5-fluorouracil in the treatment of keloids: an open clinical and histopathologic study. J Am Acad Dermatol. 2005;52:474–479.
   PubMed Web of Science ®Google Scholar
• Zhao S, Gao Y, Xia X, et al. TGF-beta1 promotes Staphylococcus aureus adhesion to and invasion into bovine mammary fibroblasts via the ERK pathway. Microb Pathog. 2017;106:25–29.
   PubMed Web of Science ®Google Scholar
• Zhang H, He F, Shi M, et al. Toll-like receptor 4-myeloid differentiation primary response gene 88 pathway is involved in the inflammatory development of polymyositis by mediating interferon-gamma and interleukin-17A in humans and experimental autoimmune myositis mouse model. Front Neurol. 2017;8:132.
   PubMed Web of Science ®Google Scholar
• Freudlsperger C, Bian Y, Contag Wise S, et al. TGF-beta and NF-kappaB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers. Oncogene. 2013;32:1549–1559.
   PubMed Web of Science ®Google Scholar
• Xia Y, Choi HK, Lee K. Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors. Eur J Med Chem. 2012;49:24–40.
   PubMed Web of Science ®Google Scholar
• Wang R, Zhou S, Li S. Cancer therapeutic agents targeting hypoxia-inducible factor-1. Curr Med Chem. 2011;18:3168–3189.
   PubMed Web of Science ®Google Scholar
• Mabjeesh NJ, Escuin D, LaVallee TM, et al. 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell. 2003;3:363–375.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Karnak D, Tan M, et al. FBXW7 facilitates nonhomologous end-joining via K63-linked polyubiquitylation of XRCC4. Mol Cell. 2016;61:419–433.
   PubMed Web of Science ®Google Scholar